An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese men

Fertility and Sterility

Volumn 94, Issue 5, 2010, Pages 1734-1738

  Hammoud, Ahmad ^a   Carrell, Douglas T ^b   Meikle, A Wayne ^b,c   Xin, Yuanpei ^b   Hunt, Steven C ^b   Adams, Ted D ^b,d   Gibson, Mark ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^d Latter Day Saints Hospital   (United States)

Author keywords

aromatase polymorphism; estradiol; hormones; Obesity; testosterone; TTTA repeats

Indexed keywords

AROMATASE; ESTRADIOL; MICROSATELLITE DNA;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; STOMACH BYPASS; WEIGHT REDUCTION; BLOOD; CASE CONTROL STUDY; GENETICS; LONGITUDINAL STUDY; MIDDLE AGED;

ADULT; AROMATASE; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; COHORT STUDIES; ESTRADIOL; FOLLOW-UP STUDIES; GASTRIC BYPASS; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC;

EID: 77957205789     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.10.037     Document Type: Article

References (43)

1. A. Tchernof, J.P. Despres, A. Belanger, A. Dupont, D. Prud'homme, and S. Moorjani Reduced testosterone and adrenal C19 steroid levels in obese men Metabolism 44 1995 513 519
2. C.X. Ma, A.A. Adjei, O.E. Salavaggione, J. Coronel, L. Pelleymounter, and L. Wang Human aromatase: gene resequencing and functional genomics Cancer Res 65 2005 11071 11082
3. S. Sebastian, and S.E. Bulun A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project J Clin Endocrinol Metab 86 2001 4600 4602
4. S.E. Bulun, S. Sebastian, K. Takayama, T. Suzuki, H. Sasano, and M. Shozu The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters J Steroid Biochem Mol Biol 86 2003 219 224
5. R. Nguyen, A. Wilcox, and R. Skjaerven DD.B. Men's body mass index and infertility Hum Reprod 22 2007 2488 2493
6. A.O. Hammoud, N. Wilde, M. Gibson, A. Parks, D.T. Carrell, and A.W. Meikle Male obesity and alteration in sperm parameters Fertil Steril 90 2008 2222 2225
7. J. Kaukua, T. Pekkarinen, T. Sane, and P. Mustajoki Sex hormones and sexual function in obese men losing weight Obes Res 11 2003 689 694
8. A. Hammoud, M. Gibson, S.C. Hunt, T.D. Adams, D.T. Carrell, and R.L. Kolotkin Effect of roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men J Clin Endocrinol Metab 94 2009 1329 1332
9. M.H. Polymeropoulos, H. Xiao, D.S. Rath, and C.R. Merril Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19) Nucleic Acids Res 19 1991 195
10. K.E. Talbott, M.D. Gammon, M.G. Kibriya, Y. Chen, S.L. Teitelbaum, and C.M. Long A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk Breast Cancer Res Treat 111 2008 481 487
11. C.S. Huang, S.H. Kuo, H.C. Lien, S.Y. Yang, S.L. You, and C.Y. Shen The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers Oncologist 13 2008 751 760
12. H. Ahsan, A.S. Whittemore, Y. Chen, R.T. Senie, S.P. Hamilton, and Q. Wang Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study Breast Cancer Res 7 2005 R71 R81
13. S.W. Baxter, D.Y. Choong, D.M. Eccles, and I.G. Campbell Polymorphic variation in CYP19 and the risk of breast cancer Carcinogenesis 22 2001 347 349
14. Y. Miyoshi, K. Iwao, N. Ikeda, C. Egawa, and S. Noguchi Breast cancer risk associated with polymorphism in CYP19 in Japanese women Int J Cancer 89 2000 325 328
15. V.N. Kristensen, T.I. Andersen, A. Lindblom, B. Erikstein, P. Magnus, and A.L. Borresen-Dale A rare CYP19 (aromatase) variant may increase the risk of breast cancer Pharmacogenetics 8 1998 43 48
16. R.A. Paynter, S.E. Hankinson, G.A. Colditz, P. Kraft, D.J. Hunter, and I. De Vivo CYP19 (aromatase) haplotypes and endometrial cancer risk Int J Cancer 116 2005 267 274
17. C.L. Tofteng, A. Kindmark, H. Brandstrom, B. Abrahamsen, S. Petersen, and F. Stiger Polymorphisms in the CYP19 and AR genes - relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study Calcif Tissue Int 74 2004 25 34 (Pubitemid 38166601)
18. I.M. Dick, A. Devine, and R.L. Prince Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women Am J Physiol Endocrinol Metab 288 2005 E989 E995
19. L. Masi, L. Becherini, L. Gennari, A. Amedei, E. Colli, and A. Falchetti Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk J Clin Endocrinol Metab 86 2001 2263 2269
20. L. Gennari, L. Masi, D. Merlotti, L. Picariello, A. Falchetti, and A. Tanini A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism J Clin Endocrinol Metab 89 2004 2803 2810
21. I. Van Pottelbergh, S. Goemaere, and J.M. Kaufman Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age J Clin Endocrinol Metab 88 2003 3075 3081
22. I. Czajka-Oraniec, W. Zgliczynski, A. Kurylowicz, M. Mikula, and J. Ostrowski Association between gynecomastia and aromatase (CYP19) polymorphisms Eur J Endocrinol 158 2008 721 727
23. D. Kastelan, Z. Grubic, I. Kraljevic, O. Polasek, T. Dusek, and K. Stingl The role of estrogen receptor-alpha gene TA polymorphism and aromatase gene TTTA polymorphism on peak bone mass attainment in males: is there an additive negative effect of certain allele combinations? J Bone Miner Metab 27 2009 198 204
24. Y.C. Huang, M. Chen, M.W. Lin, M.Y. Chung, Y.H. Chang, and W.J. Huang CYP19 TCT tri-nucleotide Del/Del genotype is a susceptibility marker for prostate cancer in a Taiwanese population Urology 69 2007 996 1000
25. N. Tsuchiya, L. Wang, H. Suzuki, T. Segawa, H. Fukuda, and S. Narita Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer J Clin Oncol 24 2006 1982 1989
26. M. Lorentzon, C. Swanson, A.L. Eriksson, D. Mellstrom, and C. Ohlsson Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study J Bone Miner Res 21 2006 332 339
27. O. Cussenot, A.R. Azzouzi, N. Nicolaiew, G. Fromont, P. Mangin, and L. Cormier Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens J Clin Oncol 25 2007 3596 3602
28. M.N. Okobia, C.H. Bunker, J.M. Zmuda, E.R. Ezeome, S.N. Anyanwu, and E.E. Uche Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women J Carcinog 5 2006 12
29. C.S. Healey, A.M. Dunning, F. Durocher, D. Teare, P.D. Pharoah, and R.N. Luben Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk Carcinogenesis 21 2000 189 193
30. S.E. Hur, S. Lee, J.Y. Lee, H.S. Moon, H.L. Kim, and H.W. Chung Polymorphisms and haplotypes of the gene encoding the estrogen-metabolizing CYP19 gene in Korean women: no association with advanced-stage endometriosis J Hum Genet 52 2007 703 711
31. N. Kado, J. Kitawaki, H. Obayashi, H. Ishihara, H. Koshiba, and I. Kusuki Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women Hum Reprod 17 2002 897 902
32. T. Salmen, A.M. Heikkinen, A. Mahonen, H. Kroger, M. Komulainen, and H. Pallonen Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women Ann Med 35 2003 282 288 (Pubitemid 36791696)
33. T. Remes, S.B. Vaisanen, A. Mahonen, J. Huuskonen, H. Kroger, and J.S. Jurvelin Aerobic exercise and bone mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor alpha gene polymorphisms small star, filled Bone 32 2003 412 420
34. T.D. Adams, E. Avelar, T. Cloward, R.D. Crosby, R.J. Farney, and R. Gress Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery Contemp Clin Trials 26 2005 534 551
35. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672
36. A.M. Dunning, M. Dowsett, C.S. Healey, L. Tee, R.N. Luben, and E. Folkerd Polymorphisms associated with circulating sex hormone levels in postmenopausal women J Natl Cancer Inst 96 2004 936 945
37. V.N. Kristensen, N. Harada, N. Yoshimura, E. Haraldsen, P.E. Lonning, and B. Erikstein Genetic variants of CYP19 (aromatase) and breast cancer risk Oncogene 19 2000 1329 1333
38. K. Suzuki, H. Nakazato, H. Matsui, H. Koike, H. Okugi, and N. Ohtake Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population Anticancer Res 23 2003 4941 4946 (Pubitemid 38182108)
39. N. Siegelmann-Danieli, and K.H. Buetow Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk Br J Cancer 79 1999 456 463
40. R. Ramirez-Lorca, A. Grilo, M.T. Martinez-Larrad, L. Manzano, F.J. Serrano-Hernando, and F.J. Moron Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants Hypertension 50 2007 884 890
41. A.L. Eriksson, M. Lorentzon, L. Vandenput, F. Labrie, M. Lindersson, and A.C. Syvanen Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men J Clin Endocrinol Metab 94 2009 1033 1041
42. M.S. Mahendroo, C.R. Mendelson, and E.R. Simpson Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue J Biol Chem 268 1993 19463 19470
43. R.J. Santen, H. Brodie, E.R. Simpson, P.K. Siiteri, and A. Brodie History of aromatase: saga of an important biological mediator and therapeutic target Endocr Rev 30 2009 343 375